HSV-1 based amplicon vectors as an alternative system for the expression of functional HCV proteins

Current Gene Therapy

Volumn 6, Issue 3, 2006, Pages 393-398

  Tsitoura, Eliza ^a   Georgopoulou, Urania ^b   Mavromara, Penelope ^b  

^a CENTRE DE GÉNÉTIQUE MOLÉCULAIRE ET CELLULAIRE   (France)

^b HELLENIC PASTEUR INSTITUTE   (Greece)

Author keywords

CE1E2p7; HCV core protein; Naked core particles; NS3 4A; Viral replication complex

Indexed keywords

CORE PROTEIN; GLYCOPROTEIN E1; GLYCOPROTEIN E2; HEPATITIS C VACCINE; NONSTRUCTURAL PROTEIN 3; SERINE PROTEINASE; STRUCTURAL PROTEIN; VIRUS PROTEIN; VIRUS VECTOR;

AMPLICON; CYTOTOXIC T LYMPHOCYTE; HEPATITIS C; HEPATITIS C VIRUS; HERPES SIMPLEX VIRUS; HETEROLOGOUS EXPRESSION; IMMUNE RESPONSE; IN VITRO STUDY; LIFE CYCLE; MAMMAL CELL; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVIEW; TREATMENT OUTCOME; VIRAL GENE DELIVERY SYSTEM;

HEPATITIS C VIRUS; HUMAN HERPESVIRUS 1; MAMMALIA;

EID: 33745194574     PISSN: 15665232     EISSN: None     Source Type: Journal    
DOI: 10.2174/156652306777592018     Document Type: Review

References (59)

1. Acosta-Rivero, N., Rodriguez, A., Musacchio, A., Falcon, V., Suarez, V.M., Chavez, L., Morales-Grillo, J. and Duenas-Carrera, S. (2004a) Nucleic acid binding properties and intermediates of HCV core protein multimerization in Pichia pastoris. Biochem. Biophys. Res. Commun., 323: 926-931.
2. Acosta-Rivero, N., Rodriguez, A., Musacchio, A., Falcon, V., Suarez, V.M., Martinez, G., Guerra, I., Paz-Lago, D., Morera, Y., de la Rosa, M.C., Morales-Grillo, J. and Duenas-Carrera, S. (2004b) In. vitro assembly into virus-like particles is an intrinsic quality of Pichia pastoris derived HCV core protein. Biochem. Biophys. Res, Commun., 325: 68-74.
3. Andre, P. Perlemuter, G., Budkowska, A., Brechot, C. and Lotteau, V. (2005) Hepatitis C virus particles and lipoprotein metabolism. Semin. Liver Dis., 25: 93-104.
4. Barba, G., Harper, F., Harada, T., Kohara, M., Goulinet, S., Matsuura, Y., Eder, G., Schaff, Z., Chapman, M. J., Miyamura, T. and Brechot, C. (1997) Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc. Natl. Acad. Sci. USA, 94: 1200-1205.
5. Bartenschlager, R. and Lohmann, V. (2001) Novel cell culture systems for the hepatitis C virus. Antiviral. Res., 52: 1-17.
6. Bartosch, B. and Cosset, F.L. (2006) Cell entry of hepatitis C virus. Viralogy.
7. Bartosch, B., Dubuisson, J. and Cosset, F. L. (2003) Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J. Exp. Med., 197: 633-642.
8. Branch, A. Stump, D.D.D., Gutierrez, J.A., Eng, F. and Walewski, J.L. (2005) The hepatitis C virus alternate wading frame (ARF) and its family of novel products: the alternate reading frame protein/F-protein, the double-frameshift protein, and others. Semin. Liver Dis., 25: 105-117.
9. Breiman, A., Grandvaux, N., Lin, R., Ottone, C., Akira, S., Yoneyama, M., Fujita, T., Hiscott, J. and Meurs, E.F. (2005) Inhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon. J. Virol., 79: 3969-3978.
10. Brown, R. S. (2005) Hepatitis C and liver transplantation. Nature, 436: 973-978.
11. Carabaich, A., Ruvoletto, M., Bernardinello, E., Tono, N., Cavalletto, L., Chemello, L., Gatta, A. and Pontisso, P. (2005) Profiles of HCV core protein and viremia in chronic hepatitis C: possible protective role of core antigen in liver damage. J. Med. Virol., 76: 55-60.
12. Cormier, E. G., Tsamis, F., Kajumo, F., Durso, R. J., Gardner, J. P. and Dragic, T. (2004) CD81 is an entry coreceptor for hepatitis C virus. Proc. Natl. Acad. Sci. USA, 101: 7270-7274.
13. Cuchet, D., Ferrera, R., Lomonte, P. and Epstein, A. L. (2005) Characterization of antiproliferative and cytotoxic properties of the HSV-1 immediate-early ICPo protein. J. Gene. Med., 7: 1187-1199.
14. Di Bisceglie, A. M. (2000) Natural history of hepatitis C: its impact on clinical management. Hepatology, 31: 1014-1018.
15. Dudek, T. and Knipe, D.M. (2006) Replication-defective viruses as vaccines and vaccine vectors. Virology, 344: 230-239.
16. Epstein, A. L. (2005) HSV-1-based amplicon vectors: design and applications. Gene Ther., 12 Suppl 1: S154-158.
17. Falcon, V., Acosta-Rivero, N., Chinea, G., de la Rosa, M.C., Menendez, I., Duenas-Carrera, S., Gra, B., Rodriguez, A., Tsutsumi, V., Shibayama, M., Luna-Munoz, J., Miranda-Sanchez, M. M., Morales-Grillo, J. and Kouri, J. (2003) Nuclear localization of nucleocapsid-like particles and HCV core protein in hepatocytes of a chronically HCV-infected patient. Biochem. Biophys. Res. Commun., 310: 54-58.
18. Farci, P., Choo, Q.L., Kuo, G., Weiner, A.J., Overby, L.R., Bradley, D.W., (2002) Houghton M. Isolation of a cDNA clone derived from a bloodborne non-A, non-B viral hepatitis genome [Science 1989;244:359-362]. J. Hepatol., 36: 582-585.
19. Favre, D. and Muellhaupt, B. (2005) Potential cellular receptors involved in hepatitis C virus entry into cells. Lipids Health Dis., 4: 9.
20. Foy, E., Li, K., Wang, C., Sumpter, R. Jr., Ikeda, M., Lemon, S.M. and Gale, M. Jr. (2003) Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science, 300: 1145-1148.
21. Gosert, R., Egger, D., Lohmann, V., Bartenschlager, R., Blum, H.E., Bienz, K. and Moradpour, D. (2003) Identification of the hepatitis C virus RNA replication complex in Huh-7 cells harboring subgenomic replicons. J. Virol., 77: 5487-5492.
22. Hong, Z., Ferrari, E., Wright-Minogue, J., Chase, R., Risano, C., Seelig, G., Lee, C.G. and Kwong, A.D. (1996) Enzymatic characterization of hepatitis C virus NS3/4A complexes expressed in mammalian cells by using the herpes simplex virus amplicon system. J. Virol., 70: 4261-4268.
23. Hoofnagle, J. H. (2002) Course and outcome of hepatitis C. Hepatology, 36: S21-29.
24. Houghton, M. and Abrignani, S. (2005) Prospects for a vaccine against the hepatitis C virus. Nature, 436: 961-966.
25. Kalamvoki, M. and Mavromara, P. (2004) Calcium-dependent calpain proteases are implicated in processing of the hepatitis C virus NS5A protein. J. Virol., 78: 11865-11878.
26. Khabar, K. C., and Polyak, S.J. (2002) Hepatitis C virus-host interactions: the NS5A protein and the interferon/chemokine systems. J. Interferon Cytokine Res., 22: 1005-1012.
27. Klein, K. C., Polyak, S. J. and Lingappa, J. R. (2004) Unique features of hepatitis C virus capsid formation revealed by de novo cell-free assembly. J. Virol., 78: 9257-9269.
28. Kunkel, M., Lorinczi, M., Rijnbrand, R., Lemon, S. M. and Watowich, S. J. (2001) Self-assembly of nucleocapsid-like particles from recombinant hepatitis C virus core protein. J. Virol., 75: 2119-2129.
29. Kwong, A. D., Kim, J. L., Rao, G., Lipovsek, D. and Raybuck, S. A. (1998) Hepatitis C virus NS3/4A protease. Antiviral. Res., 40: 1-18.
30. Kwong, A. D., Kim, J. L., Rao, G., Lipovsek, D. and Raybuck, S. A. (1999) Hepatitis C virus NS3/4A protease. Antiviral. Res., 41: 67-84.
31. Lanford, R. E. and Bigger, C. (2002) Advances in model systems for hepatitis C virus research. Virology, 293: 1-9.
32. Lavillette, D., Bartosch, B., Nourrisson, D., Verney, G., Cosset, F.L., Penin, F. and Pecheur, E. I. (2006) Hepatitis C Virus Glycoproteins Mediate Low pH-dependent Membrane Fusion with Liposomes. J. Biol. Chem., 281: 3909-3917.
33. Lin, C., Lindenbach, B. D., Pragai, B. M., McCourt, D. W. and Rice, C. M. (1994) Processing in the hepatitis C virus E2-NS2 region: ideentification of p7 and two distinct E2-specific products with different C termini. J. Virol., 68: 5063-5073.
34. Lindenbach, B. D., Evans, M. J., Syder, A. J., Wolk, B., Tellinghuisen, T. L., Liu, C. C., Maruyama, T., Hynes, R. O., Burton, D. R., McKeating, J. A. and Rice, C. M. (2005) Complete replication of hepatitis C virus in cell culture. Science, 309: 623-626.
35. Logvinoff, C. and Epstein, A. L. (2000) Genetic engineering of herpes simplex virus and vector genomes carrying loxP sites in cells expressing Cre recombinase. Virology, 267: 102-110.
36. Lohmann, V., Koch, J. O. and Bartenschlager, R. (1996) Processing pathways of the hepatitis C virus proteins. J. Repatol., 24: 11-19.
37. Lorenzo, L. J., Duenas-Carrera, S., Falcon, V., Acosta-Rivero, N., Gonzalez, E., de la Rosa, M. C., Menendez, I. and Morales, J. (2001) Assembly of truncated HCV core antigen into virus-like particles in Escherichia coli. Biochem. Biophys. Res. Commun., 281: 962-965.
38. Lozach, P. Y., Amara, A., Bartosch, B., Virelizier, J. L., Arenzana-Seisdedos, F., Cosset, F. L. and Altmeyer, R. (2004) C-type lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C, virus pseudotype particles. J. Biol. Chem., 279: 32035-32045.
39. Macdonald, A. and Harris, M. (2004) Hepatitis C virus NS5A: tales of a promiscuous protein. J. Gen. Virol., 85: 2485-2502.
40. Maillard, P., Krawczynski, K., Nitkiewicz, J., Bronnert, C., Sidorkiewicz, M., Gounon, P., Dubuisson, J., Faure, G., Crainic, R. and Budkowska, A. (2001) Nonenveloped nucleocapsids of hepatitis C virus in the serum of infected patients. J. Virol., 75: 8240-8250.
41. McLauchlan, J. (2000) Properties of the hepatitis C virus core protein: a structural protein that modulates cellular processes. J. Virol. Hepat., 7: 2-14.
42. Meylan, E., Curran, J., Hofmann, K., Moradpour, D., Binder, M., Bartenschlager, R. and Tschopp, J. (2005) Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature, 437: 1167-1172.
43. Penin, F. (2003) Structural biology of hepatitis C virus. Clin. Liver Dis., 7: 1-21, vii.
44. Penin, F., Dubuisson, J., Rey, F. A., Moradpour, D. and Pawlotsky, J. M. (2004) Structural biology of hepatitis C virus, Hepatology, 39: 5-19.
45. Pietschmann, T. and Bartenschlager, R. (2003) Tissue culture and animal models for hepatitis C virus. Clin. Liver Dis., 7: 23-43.
46. Pohlmann, S., Zhang, J., Baribaud, F., Chen, Z., Leslie, G. L, Lin, G., Granelli-Piperno, A., Doms, R. W., Rice, C. M., and McKeating, J. A. (2003) Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR. J. Virol., 77: 4070-4080.
47. Ray, R. B. and Ray, R. (2001) Hepatitis C virus core protein: intriguing properties and functional relevance. FEMS Microbiol. Lett., 202: 149-156.
48. Reyes, G. R. (2002) The nonstructural NS5A protein of hepatitis C virus: an expanding, multifunctional role in enhancing hepatitis C virus pathogenesis. J. Biomed. Sci., 9: 187-197.
49. Rouille, Y., Helle, F., Delgrange, D., Roingeard, P., Voisset, C., Blanchard, E., Belouzard, S., McKeating, J., Patel, A. H., Maertens, G., Wakita, T., Wychowski, C. and Dubuisson, J. (2006) Subcellular localization of hepatitis C virus structural proteins in a cell culture system that efficiently replicates the virus. J. Virol., 80: 2832-2841.
50. Suzuki, R., Sakamoto, S., Tsutsumi, T., Rikimaru, A., Tanaka, K., Shimoike, T., Moriishi, K., Iwasaki, T., Mizumoto, K., Matsuura, Y., Miyamura, T. and Suzuki, T. (2005) Molecular determinants for subcellular localization of hepatitis C virus core protein. J. Virol., 79: 1271-1281.
51. Tsitoura, E., Lucas, M., Revol-Guyot, V., Epstein, A. L., Manservigi, R. and Mavromara, P. (2002) Expression of hepatitis C virus envelope glycoproteins by herpes simplex virus type 1-based amplicon vectors. J. Gen. Virol., 83: 561-566.
52. Varaklioti, A., Vassilaki, N., Georgopoulou, U. and Mavromara, P. (2002) Alternate translation occurs within the core coding region of the hepatitis C viral genome. J. Biol. Chem., 277: 17713-17721.
53. Voisset, C. and Dubuisson, J. (2004) Functional hepatitis C virus envelope glycoproteins. Biol. Cell., 96: 413-420.
54. Wakita, T., Pietschmann, T., Kato, T., Date, T., Miyamoto, M., Zhao, Z., Murthy, K., Habermann, A., Krausslich, H. G., Mizokami, M., Bartenschlager, R. and Liang, T.J. (2005) Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med., 11: 791-796.
55. Walewski, L L., Keller, T. R., Stump, D.D. and Branch, A.D. (2001) Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame. RNA, 7: 710-721.
56. Watashi, K. and Shimotohno, K. (2003) The roles of hepatitis C virus proteins in modulation of cellular functions: a novel action mechanism of the HCV core protein on gene regulation by nuclear hormone receptors. Cancer Sci., 94: 937-943.
57. Xu, Z., Choi, J., Yen, T. S., Lu, W., Strohecker, A., Govindarajan, S., Chien, D., Selby, M. J. and Ou, J. (2001) Synthesis of a novel hepatitis C virus protein by ribosomal frameshift. EMBO J., 20: 3840-3848.
58. Zaupa, C., Revol-Guyot, V. and Epstein, A.L. (2003) Improved packaging system for generation of high-level noncytotoxic HSV-1 amplicon vectors using Cre-loxP site-specific recombination to delete the packaging signals of defective helper genomes. Hum. Gene Ther., 14: 1049-1063.
59. Zhong, J., Gastaminza, P., Cheng, G., Kapadia, S., Kato, T., Burton, D. R., Wieland, S. F., Uprichard, S. L., Wakita, T. and Chisari, F. V. (2005) Robust hepatitis C virus infection in vitro. Proc. Natl. Acad. Sci. USA, 102: 9294-9299.